Diagnostics, Earnings Announcements

Nectar Lifesciences Ltd. announced earnings results for the quarter ended December 2007. For the quarter, the Company reported an 18% increase in net profit at INR 179.8 million and its sales increased by 42% to INR 1,730.7 million. Operating profit increased by 50% to INR 303.7 million.

Dishman Pharmaceuticals and Chemicals Ltd. reported earnings results for the quarter to December 2007. The company reported 6% increase in net profit at INR 210.2 million for the quarter to Dec. 2007. Sales increased by 25% to INR 1,001.5 million. The company's operating profit increased by 10% to INR 281.5 million.

Alembic Ltd. announced earnings results for the quarter ended December 2007. For the quarter, the Company reported an 23% decrease in net profit at INR 194.7 million and its sales increased by 40% to INR 2,566.4 million. Operating profit decreased by 12% to INR 294.5 million.

DIVI'S Laboratories Ltd. reported earnings results for the quarter to December 2007. The company has announced a 208% increase in net profit at INR 1,006.6 million for the quarter to December 2007. Its sales increased by 90% to INR 2,842.2 million.

Suven Life Sciences Ltd. reported earnings results for the quarter to December 2007. For the period, the company reported a 48% decrease in net profit at INR 20.1 million,sales decreased by 12% to INR 274.6 million.

Galapagos Genomics NV reported earnings results for the year 2007. The company reported net loss for full-year 2007 was €21.9 million ($33.6 million), or €1.06 per share, versus €11.3 million, or €0.84 per share the year before, due to a steep rise in R&D costs, from €15.9 million to €30.6 million. Galapagos' full-year 2007 revenues grew 87% to €65.9 million, with a €48.4 million contribution from BioFocus DPI, including €5.4 million from inter-company revenues that were eliminated in the consolidation.

Tepnel Life Sciences plc reported earnings results for the year ended December 31, 2007. For the year, the company reported net profit of £1,244,000 or 0.50 pence diluted earnings per share on revenue £18,337,000 against net profit of £368,000 or 0.16 pence diluted earnings per share on revenue £16,156,000 for the same period a year ago.

Dr. Reddy's Laboratories Ltd. has announced a 92% decrease in net profit at INR 422.9 million for the quarter to Dec. 2007. Its sales decreased by 34% to INR 7,755.5 million. The company's operating profit decreased by 88% to INR 681.4 million and its profit before depreciation and tax declined by 83% to INR 1,015.7 million.